NEW YORK, Aug. 10, 2015 /PRNewswire/ -- Aisling
Capital, a leading investment firm that invests in companies
developing and commercializing important and innovative healthcare
products, services and technologies, announced that Scott Braunstein, MD has joined the firm as an
Operating Partner. Dr. Braunstein will assist in evaluating
potential future investments for the firm, as well as working
broadly with Aisling portfolio companies.
"Scott has over 25 years of experience in the healthcare
industry in a variety of clinical, business, strategy, product and
technology leadership roles. We are delighted to welcome him to
Aisling Capital," said Drew Schiff,
MD, Managing Partner at Aisling Capital. "In his new role, Scott
will contribute his unique insights and perspectives to our
late-stage private equity investment strategies."
Dr. Braunstein serves as Senior Vice President, Strategy and
Corporate Development at Pacira Pharmaceuticals. He spent 12
years as a Healthcare Analyst and Portfolio Manager at J.P. Morgan
Asset Management, where he invested in and conducted diligence on a
wide variety of pharmaceutical products and product candidates. He
reviewed pharmaceutical company strategies, business models and
management teams, and provided stock recommendations for the J.P.
Morgan Asset Equity Group.
"I am very excited to join Aisling Capital and its talented
team," said Dr. Braunstein. "I am looking forward to working across
the firm's impressive portfolio of healthcare companies to help
them better meet their business objectives, as well as identifying
new investment opportunities."
Dr. Braunstein serves as a director of Esperion Therapeutics
(Nasdaq: ESPR), STAT Medical and the Cornell Alumni Association for
the College of Agriculture and Life Sciences. Dr. Braunstein
received his M.D. from the Albert Einstein College of Medicine and
completed his residency in internal medicine at Cornell University-New York Hospital. He
received his B.S. from Cornell
University.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/scott-braunstein-joins-aisling-capital-as-operating-partner-300126123.html
SOURCE Aisling Capital